Table 2

Identified reasons for non-treatment with SGLT2i

Identified reasons for non-treatment with SGLT2i
Contraindications
 eGFR <30 mL/min/1.73 m215 (12.9%)
 Adverse events11 (9.5%)
 Kidney transplant7 (6.0%)
Other
 Patient/GP related6 (5.2%)
No reason identified77 (66.4%)
  • Data presented are frequency (%).

  • eGFR, estimated glomerular filtration rate; GP, general practitioner; SGLT2i, sodium-glucose cotransporter 2 inhibitor.